| GenVec and Fuso in Cancer Research Collaboration |
Abstract
pdf
|
|
Business Review Editor |
|
| Biogen in Research Alliance with Sunesis |
Abstract
pdf
|
|
Business Review Editor |
|
| Perlegen Enters into 3 Big Pharma Genomics Collaborations |
Abstract
pdf
|
|
Business Review Editor |
|
| SkyePharma in Separate Licensing and Drug Delivery Technology Sharing Agreements |
Abstract
pdf
|
|
Business Review Editor |
|
| Theravance and GSK in Alliance to Develop Respiratory Drugs |
Abstract
pdf
|
|
Business Review Editor |
|
| Pfizer Licenses Phase III AMD Drug from Eyetech |
Abstract
pdf
|
|
Business Review Editor |
|
| NeuroSearch and GSK in Depression Deal |
Abstract
|
|
Business Review Editor |
|
| Using Options in Pharmaceutical Licensing |
Abstract
|
|
Business Review Editor |
|
| Technology Focus: Stem Cells |
Abstract
|
|
Business Review Editor |
|
| Merck to Acquire Remaining 49% of Banyu for US$1.52 B |
Abstract
pdf
|
|
Business Review Editor |
|
| GSK Acquires Dermatology Products from Elan |
Abstract
pdf
|
|
Business Review Editor |
|
| Purdue Pharma Acquires Shire’s OTC Portfolio for US$72 M |
Abstract
pdf
|
|
Business Review Editor |
|